Evolent Health, Inc (EVH) Trading Down 2.7%
Evolent Health, Inc (NYSE:EVH) shares dropped 2.7% on Tuesday . The company traded as low as $10.30 and last traded at $11.45. Approximately 1,410,300 shares changed hands during trading, an increase of 16% from the average daily volume of 1,215,002 shares. The stock had previously closed at $11.15.
EVH has been the topic of a number of recent analyst reports. BidaskClub lowered Evolent Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. ValuEngine lowered Evolent Health from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Robert W. Baird set a $35.00 price objective on Evolent Health and gave the stock a “buy” rating in a report on Tuesday, August 8th. Cowen and Company restated an “outperform” rating and set a $33.00 price objective (down from $35.00) on shares of Evolent Health in a report on Wednesday, August 9th. Finally, Zacks Investment Research downgraded Evolent Health from a “hold” rating to a “sell” rating in a report on Thursday, August 10th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have assigned a buy rating to the company. Evolent Health has a consensus rating of “Buy” and a consensus target price of $28.70.
The company has a debt-to-equity ratio of 0.11, a current ratio of 3.34 and a quick ratio of 3.34.
Evolent Health (NYSE:EVH) last released its quarterly earnings results on Thursday, November 2nd. The technology company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. Evolent Health had a negative net margin of 15.86% and a negative return on equity of 5.05%. The business had revenue of $107.90 million for the quarter, compared to the consensus estimate of $104.49 million. During the same quarter last year, the firm earned ($0.26) EPS. Evolent Health’s revenue for the quarter was up 79.2% on a year-over-year basis. research analysts expect that Evolent Health, Inc will post -0.57 EPS for the current year.
A number of large investors have recently added to or reduced their stakes in EVH. Gradient Investments LLC lifted its position in shares of Evolent Health by 3.0% during the second quarter. Gradient Investments LLC now owns 16,719 shares of the technology company’s stock worth $424,000 after purchasing an additional 489 shares in the last quarter. American International Group Inc. lifted its position in shares of Evolent Health by 7.5% during the first quarter. American International Group Inc. now owns 9,403 shares of the technology company’s stock worth $210,000 after purchasing an additional 653 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its position in shares of Evolent Health by 6.0% during the first quarter. Schwab Charles Investment Management Inc. now owns 63,180 shares of the technology company’s stock worth $1,409,000 after purchasing an additional 3,591 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Evolent Health by 3.1% during the first quarter. Geode Capital Management LLC now owns 130,053 shares of the technology company’s stock worth $2,900,000 after purchasing an additional 3,889 shares in the last quarter. Finally, ETF Managers Group LLC acquired a new position in shares of Evolent Health during the second quarter worth approximately $102,000. Hedge funds and other institutional investors own 92.74% of the company’s stock.
Evolent Health Company Profile
Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.
Receive News & Stock Ratings for Evolent Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc and related stocks with our FREE daily email newsletter.